Nanophoria Bioscience
CONTACT
  • About us
    • About NanoPhoria
    • Team
    • Investors
  • Therapeutic focus
  • Our Platform
    • Drug Delivery Platform
    • Pipeline
    • Background Science
  • Clinical Programs
    • NP-MP1
  • News
    • Press releases

Author: Ed Gover

European Biotechnology 2026 European Start-ups to Watch

Posted on 30 March 202617 August 2026 by Ed Gover
European Biotechnology 2026 European Start-ups to Watch
Posted in In the Media

Scrip Asks 2026

Posted on 9 January 202617 August 2026 by Ed Gover
Scrip Asks 2026
Posted in In the Media

Wired Italia, Start-ups to Watch

Posted on 1 January 202617 August 2026 by Ed Gover
Wired Italia, Start-ups to Watch
Posted in In the Media

Milano Finanza, Record-breaking Italian biotech

Posted on 24 October 202517 August 2026 by Ed Gover
Milano Finanza, Record-breaking Italian biotech
Posted in In the Media

Bionity, The Largest Ever Italian Biotech Series A Round

Posted on 13 October 202517 August 2026 by Ed Gover
Bionity, The Largest Ever Italian Biotech Series A Round
Posted in In the Media

Pharma Journalist, NanoPhoria Secures €83.5m Series A

Posted on 8 October 202517 August 2026 by Ed Gover
Pharma Journalist, NanoPhoria Secures €83.5m Series A
Posted in In the Media

BioXConomy, NanoPhoria Raises $97.6m

Posted on 8 October 202517 August 2026 by Ed Gover
BioXConomy, NanoPhoria Raises $97.6m
Posted in In the Media

Alessio Alogna, one of the founders of NanoPhoria, presented our inhalation-based approach to treat HFrEF in a large animal model at the American Heart Association’s annual Scientific Sessions event, which was held this year in Chicago (AHA 2022)

Posted on 5 November 202210 February 2026 by Ed Gover
Posted in Press Release

NanoPhoria is on LinkedIn

Posted on 1 June 202210 February 2026 by Ed Gover
Posted in Press Release

NanoPhoria receives a 3.5M€ seed grant from Sofinnova Partners a leading European life sciences venture capital firm based in Paris, London and Milan

Posted on 22 May 202210 February 2026 by Ed Gover
Posted in Press Release

Posts navigation

Older posts

Recent Posts

  • BioCentury Emerging Company Profile
  • NanoPhoria Awarded Second-Place Prize in INNLIFES’ “I Protagonisti Dell’innovazione 2026” Contest
  • European Biotechnology 2026 European Start-ups to Watch
  • NanoPhoria Announces Second Close of its Series A Round, Now with Participation from European Innovation Council Fund 
  • Scrip Asks 2026

Recent Comments

No comments to show.

Archives

  • June 2026
  • May 2026
  • March 2026
  • January 2026
  • December 2025
  • October 2025
  • February 2025
  • January 2024
  • November 2022
  • June 2022
  • May 2022

Categories

  • In the Media
  • Press Release
Connect with us
Learn more about our company and the science behind our revolutionary technology platform
Get in touch
Terms of use
Privacy Policy
Cookies

© NanoPhoria S.r.l. All rights reserved.
VAT number: 12246020965